Trade NTRA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Natera, Inc. (NTRA) is trading at US$401.99, down 5.56% today as of Oct 6, 14:18 EDT. The company has a market capitalisation of US$47.86B. Over the past 52 weeks, NTRA has traded between US$167.33 and US$427.47. On Syfe you can trade NTRA with $0 commission and add it to your watchlist.
| Previous close | US$425.64 |
|---|---|
| Market cap | US$47.86B |
| 52-week range | US$167.33 – US$427.47 |
| Volume | 2.02M |
| Exchange | US |
Natera, Inc.
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Year: 2015
Natera, Inc. (NTRA) stock is trading at US$401.99, -5.56% from the previous close of US$425.64.
The market cap for Natera, Inc. (NTRA) stock is approximately US$47.86B.
The 52-week high for Natera, Inc. (NTRA) stock is US$427.47.
The 52-week low for Natera, Inc. (NTRA) stock is US$167.33.
Natera, Inc. (NTRA) does not currently pay a dividend.
Stay on top of NTRA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
